Follow
Evangelia Daskalaki
Evangelia Daskalaki
Postdoctoral Researcher, Karolinska Institute
Verified email at ki.se
Title
Cited by
Cited by
Year
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells
S Eisinger, D Sarhan, VF Boura, I Ibarlucea-Benitez, S Tyystjärvi, ...
Proceedings of the National Academy of Sciences 117 (50), 32005-32016, 2020
1052020
Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men
J Durussel, E Daskalaki, M Anderson, T Chatterji, DH Wondimu, ...
PloS one 8 (2), e56151, 2013
822013
Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
JM Harder, C Guymer, JPM Wood, E Daskalaki, G Chidlow, C Zhang, ...
Proceedings of the National Academy of Sciences 117 (52), 33619-33627, 2020
662020
Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies
J Durussel, DW Haile, K Mooses, E Daskalaki, W Beattie, M Mooses, ...
Physiological genomics 48 (3), 202-209, 2016
642016
A study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output
E Daskalaki, G Blackburn, G Kalna, T Zhang, N Anthony, DG Watson
Metabolites 5 (1), 119-139, 2015
602015
Effects of EPO on blood parameters and running performance in Kenyan athletes
DW Haile, J Durussel, W Mekonen, N Ongaro, E Anjila, M Mooses, ...
Medicine and science in sports and exercise 51 (2), 299-307, 2019
482019
Metabolomic profiling of submaximal exercise at a standardised relative intensity in healthy adults
A Muhsen Ali, M Burleigh, E Daskalaki, T Zhang, C Easton, DG Watson
Metabolites 6 (1), 9, 2016
432016
The influence of culture media upon observed cell secretome metabolite profiles: The balance between cell viability and data interpretability
E Daskalaki, NJ Pillon, A Krook, CE Wheelock, A Checa
Analytica chimica acta 1037, 338-350, 2018
422018
Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
M Dyczynski, M Vesterlund, AC Björklund, V Zachariadis, J Janssen, ...
Cell death & disease 9 (9), 846, 2018
412018
The application of metabolomic profiling to the effects of physical activity
E Daskalaki, C Easton, D G Watson
Current Metabolomics 2 (4), 233-263, 2014
332014
Precision of the optimized carbon monoxide rebreathing method to determine total haemoglobin mass and blood volume
J Durussel, R Ross, PR Kodi, E Daskalaki, P Takas, J Wilson, B Kayser, ...
European Journal of Sport Science 13 (1), 68-77, 2013
232013
Cytoplasmic citrate flux modulates the immune stimulatory NKG2D ligand MICA in cancer cells
SH Møller, M Mellergaard, M Madsen, AV Bermejo, SD Jepsen, ...
Frontiers in immunology 11, 556518, 2020
112020
Blood gene expression profiles of Kenyan and Caucasian endurance trained males after rHuEpo administration
J Durussel, JD McClure, MW McBride, DH Wondimu, W Crawford, ...
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 45 (5), 404-404, 2013
42013
Blood parameters and running performance of Kenyan and Caucasian endurance trained males after rHuEpo administration
DH Wondimu, J Durussel, W Mekonnen, E Anjila, N Ongaro, M Rutto, ...
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 45 (5), 404-405, 2013
32013
Activity update from the early career members network
DB Liesenfeld, NJW Rattray, JJJ van der Hooft, E Daskalaki, RJM Weber, ...
Metabolomics 11, 247-248, 2015
22015
Validation of Blood Gene Expression Profiles Post Recombinant Human Erythropoietin Administration: 2258 May 30, 10: 45 AM-11: 00 AM
J Durussel, JD McClure, MW McBride, DH Wondimu, W Crawford, ...
Medicine & Science in Sports & Exercise 46 (5S), 597, 2014
12014
An exploration of the potential of metabolomics for the detection of recombinant human erythropoietin (r-HuEPO) abuse in sport
E Daskalaki
2015
Haemoglobin Mass and Running Time Trial Performance after Recombinant Human Erythropoietin...
J Durussel, E Daskalaki, D Wondimu, Y Pitsiladis
2013
Haemoglobin Mass and Running Time Trial Performance after Recombinant
J Durussel, E Daskalaki, M Anderson, T Chatterji, DH Wondimu
2013
Endurance Performance, Total Haemoglobin Mass and Blood Volume Post Recombinant Human Erythropoietin Use in Trained Individuals
J Durussel, T Chatterji, E Daskalaki, D Haile, Z Bekele, N Padmanabhan, ...
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 44, 913-913, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–20